Ovation Science announced the signing of an exclusive licensing agreement for Ovation’s products for Canada with Ripco Processing Inc. a company based in Calgary, Alberta and founded by successful legal cannabis pioneers.
Explore the cutting-edge world of Ovation Science with CEO Terry Howlett and Anil Mall, as they discuss the company's innovative CBD/THC skincare products and patented Invisicare® technology in this episode.
Ovation’s President Terry Howlett recently appeared on The Watchlist to discuss the company’s latest License Agreement for its topical/transdermal cannabis products in Missouri.
Ovation Science announced the signing of an exclusive licensing agreement for Ovation’s topical / transdermal formulations for the state of Missouri.
Ovation Science is pleased to announce the appointment of Shane Dungey and Ronald Stern to the Board of Directors.
Ovation Science announces that there was an error in its news release dated October 12, 2023. The Company issued 4,000,000 Units at a price of $0.05 per unit for gross proceeds of $200,000.
Ovation Science announces a proposed private placement offering of up to 4,000,000 units (each a “Unit”) at a price of $0.05 per Unit for total proceeds of up to $200,000 (the “Offering”).
Ovation Science with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare® announced the signing of an exclusive licensing agreement with Planet 13 Holdings, Inc.
Ovation Science is pleased to announce it has entered into an exclusive licensing agreement with PA Options for Wellness Inc. for Pennsylvania. PA Options, founded in 2014, has six dispensaries doing business as Vytal Options.
Ovation Science has signed a Supply and Distribution Agreement with Golfer’s CBD Ltd., an international CBD brand focused on the health and wellness of golfers around the world.
